MPM BioVentures 2014, L.P. Offloads 259,837 Shares of Entrada Therapeutics (NASDAQ: TRDA) at $7.11-$7.41 Each
Kalkine Media
MPM BioVentures 2014, L.P. sold 259,837 shares of Entrada Therapeutics (NASDAQ: TRDA) between September 4 and September 9, 2026, at prices ranging from $7.11 to $7.41 per share. Following these transactions, the insider's reported ownership stands at 3,885,115 shares. These sales were executed as open-market transactions, and MPM BioVentures 2018, L.P. is also noted as an insider.
Read the full story
This is a short summary. The complete article is published by Kalkine Media.
Headline and summary aggregated from public news feeds. For information only — not financial advice.